Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Talos Energy
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
New CEO And Gulf Of Mexico Projects May Improve Future Prospects, But Analysts Foresee Challenges And Operational Risks Persist
Key Takeaways New CEO Paul Goodfellow's leadership is expected to improve operational efficiency, enhancing revenue and earnings growth through strategic execution. Strong free cash flow and robust reserves position Talos Energy for debt reduction, potential shareholder returns, and long-term revenue growth.
View narrative
US$13.17
FV
40.6% undervalued
intrinsic discount
-2.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
Borosil
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Shifting To Domestic Production Will Expand Capacity And Reduce Import Reliance
Key Takeaways Expansion of production capacity and focus on premium lines is set to enhance revenue growth and strengthen brand leadership. Shift to online sales and domestic production could improve revenue and margins, despite short-term cost pressures.
View narrative
₹420.00
FV
22.9% undervalued
intrinsic discount
11.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 days ago
author updated this narrative
MilDef Group
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Digitalization And Integration Will Empower European Defense Modernization
Key Takeaways Expansion into system integration and advanced digital defense solutions is boosting margins and driving predictable, recurring revenue streams. Strategic acquisitions and European market alignment are reducing earnings volatility while supporting sustained growth and geographic diversification.
View narrative
SEK 258.00
FV
37.2% undervalued
intrinsic discount
44.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
3 days ago
author updated this narrative
Mahindra Holidays & Resorts India
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Indian Tourism Investment And Digital Platforms Will Drive Leisure Travel
Key Takeaways Long-term growth is supported by rising domestic demand, digital customer acquisition, and capital-light expansion strategies to boost both recurring revenues and profitability. Focus on sustainability, quality upgrades, and curated experiences is expected to improve customer retention and increase member lifetime value, enhancing margins.
View narrative
₹510.00
FV
31.0% undervalued
intrinsic discount
-10.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
3 days ago
author updated this narrative
Pharma Mar
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
EMA Approval And Global Launch Will Expand Oncology Markets
Key Takeaways Expanding product launches, strategic global partnerships, and strong R&D investments position PharmaMar for sustained growth and diversified revenue streams despite competitive pressures. Advances in marine-derived oncology therapies and inclusion in clinical guidelines enhance market relevance, supporting higher margins and long-term earnings potential.
View narrative
€104.60
FV
24.4% undervalued
intrinsic discount
39.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
3 days ago
author updated this narrative
Supriya Lifescience
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Expansion Into Regulated Markets And CMO/CDMO Opportunities To Strengthen Future Prospects
Key Takeaways Supriya Lifescience's product launches and market penetration in regulated regions aim to enhance revenue growth and net margins. Strategic capacity expansion and decreased reliance on China signal potential long-term earnings and margin stability.
View narrative
₹843.00
FV
22.0% undervalued
intrinsic discount
19.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
SPG
SP Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
Key Takeaways Strong growth in proprietary products and a new factory in Atlanta suggest potential for increased revenue and improved margins. Commitment to sustainability and a share buyback program may boost eco-conscious customer appeal and shareholder value.
View narrative
DKK 390.00
FV
30.6% undervalued
intrinsic discount
5.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
BWP Trust
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Suburban Retail Will Stumble Amid E-Commerce And Bunnings Challenges
Key Takeaways BWP Trust faces risks from reliance on Bunnings, limited diversification, and shifts toward e-commerce and smaller retail formats reducing demand for its properties. Rising interest rates, increased capital expenditures, and changing retailer strategies threaten earnings stability, net margins, and long-term asset values.
View narrative
AU$3.86
FV
5.6% undervalued
intrinsic discount
3.31%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
Afry
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Decarbonization And Asian Renewables Will Drive Future Energy Demand
Key Takeaways Rising global decarbonization and infrastructure trends, plus expansion in growth markets, are driving robust demand and revenue diversification for AFRY across energy and industrial sectors. Restructuring, portfolio optimization, and a focus on high-value consulting are expected to strengthen efficiency, margin quality, and recurring revenue streams.
View narrative
SEK 213.75
FV
29.6% undervalued
intrinsic discount
3.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies